23andMe's former CEO agrees to buy the company for $305 million

Anne Wojcicki is poised to regain control of genetics testing company 23andMe, which she cofounded and led until earlier this year, after agreeing to put much of her personal fortune on the line.
Why it matters: This is the same person that 23andMe customers originally trusted with their personal data, albeit under a much more opaque governance structure.
Catch up quick: Regeneron Pharma in May won a bankruptcy auction for 23andMe's assets, bidding $265 million, beating out Wojcicki (who'd been trying to purchase the company since well before the Chapter 11 filing).
The move sparked both congressional inquiry and lawsuits, including from 27 state attorneys general who claim a sale can't occur without consumer consent.
Wojcicki fought to get the auction reopened, and on Friday reached an agreement to buy the 23andMe assets for $305 million.
A Regeneron spokesperson says the company "declined to submit a new bid ... based on our assessment of 23andMe's remaining value." Or, as Regeneron CEO Leonard Schleifer told CNBC's Becky Quick, "the juice isn't worth the squeeze."
Behind the scenes: Wojcicki made the offer through TTAM Research Institute, a public-benefit corporation formed just last month.
She is the only person listed on TTAM's only filing with the California secretary of state, and the 335-page merger agreement doesn't list any other executives.
Wojcicki originally told the court that she had the support of an undisclosed Fortune 500 company, which some reporters speculated was Oracle, but no such company appears in any of the relevant documents.
Sources tell Axios that the entire $305 million comes from Wojcicki herself, and that 23andMe's special committee verified that she has the necessary funds.
Look ahead: A court hearing to approve Wojcicki's bid is scheduled for tomorrow.
The bottom line: Even if she clears all the legal hurdles, it remains unclear how Wojcicki plans to make 23andMe into a viable business (even if under a nonprofit umbrella).

Try Our AI Features

Explore what Daily8 AI can do for you:

Learn with AIFact CheckingText to SpeechAI Summary

Related Articles

Yahoo

6 hours ago

• Yahoo

Sanofi (ENXTPA:SAN) Gains FDA Approval For Dupixent To Address Rare Skin Disease

Sanofi experienced a 4% decline over the past week despite a largely unchanged market. The recent events, including the FDA approval of Dupixent for a rare skin condition and the signing of a memorandum with the Department of Health - Abu Dhabi, signal positive developments for its collaborative efforts with Regeneron and internal growth strategies. Although these announcements are significant, they were not sufficient to counteract the broader move, which might have been influenced by other factors specific to Sanofi, such as its recent €1.5 billion notes offering aimed at supporting corporate purposes. Buy, Hold or Sell Sanofi? View our complete analysis and fair value estimate and you decide. Explore 26 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research. The recent developments for Sanofi, including FDA approval of Dupixent for a rare skin condition and the memorandum with the Department of Health - Abu Dhabi, highlight efforts to enhance revenue growth through expanded market reach and innovation. Despite these positive updates, Sanofi shares experienced a 4% decline over the past week, influenced by factors such as the recent €1.5 billion notes offering. Over a longer-term period, Sanofi achieved a total shareholder return of 11.29% over five years. Comparatively, over the past year, Sanofi's performance matched the French Pharmaceuticals industry, which reported a similar decline of 5.9%. In contrast, the broader French Market fared slightly better, returning 2.2%. The recent news related to Dupixent and international partnerships could potentially boost Sanofi's revenue and earnings forecasts, providing a catalyst for future growth given the innovative pipeline and market penetration opportunities. Considering the current share price of €95.9 and the analyst consensus price target of €117.7, there is potential for an 18.5% increase, according to market projections. These developments need to be weighed against existing market conditions and company fundamentals, as analysts remain divided on future earnings prospects and valuations. Click here to discover the nuances of Sanofi with our detailed analytical financial health report. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include ENXTPA:SAN. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@

Miami Herald

10 hours ago

• Miami Herald

Struggling restaurant chain likely to shut down or be sold

Sometimes, the small things get lost when owned by a large company. In multiple cases, Chipotle shut down nascent brands because it seemed impossible for them to grow to a point where they materially impacted earnings. That's also partially why McDonald's sold its stake in Chipotle, well before the Mexican chain became the giant it has grown into. McDonald's itself recently closed down its CosMc's experiment because it made more sense to integrate some of that chain's beverage menu into the core brand rather than growing another chain. Related: Taco Bell menu tries wild items, new kind of shell It's hard to be a small brand at a company that owns multiple larger brands, because it's not worth it for management to focus efforts on your growth. When a company owns multiple major restaurant chains with high growth potential, it may not be the right owner for a smaller, more niche chain. Don't miss the move: Subscribe to TheStreet's free daily newsletter That's not a comment on whether than chain offers good food - McDonald's probably always liked the menu at Chipotle - but a decision as to where resources can best be used. Darden Restaurants Inc. (DRI) has come to that decision about one of its brands, and the end of that relationship may not be pretty. Darden has decided to walk away from the Bahama Breeze brand. That's something CEO Ricardo Cardenas talked about during his company's fourth-quarter earnings call. "We made the decision to close 15 Bahama Breeze locations in May, leaving the 28 highest-performing Bahama Breeze restaurants in our portfolio. After further review, we have made the difficult decision that these remaining locations and the Bahama Breeze brand are not a strategic priority for us. We also believe that this brand and these restaurants have the potential to benefit from a new owner," he shared. While a sale is a possibility, other options are being considered. "Consequently, we will be considering strategic alternatives for Bahama Breeze, including a potential sale of the brand, or converting restaurants to other Darden brands. Excluding any onetime potential impacts, which are unknown as of today, we do not expect these strategic alternatives including a potential sale to have a material impact on our financial results," he added. The CEO offered more color on the decision to shut down or sell Bahama Breeze. "And then lastly, on the decision on Bahama Breeze, we have, when we look at our portfolio and we try to determine what brands we add to our portfolio, we have criteria. And [those] criteria should be what we look at to keep brands in our portfolio," he shared. More Food and Retail: Another healthy fast-food chain files Chapter 11 bankruptcyCostco quietly pulls popular product, upsets fansStarbucks brings back fan-favorite menu item after 2-year hiatus Bahama Breeze, he noted, no longer fits the criteria. "And we think that they have a lot of growth potential with another owner. We were not going to be putting a lot of investment into Bahama Breeze. And so to give those team members and those managers growth opportunities, it's better for them to be under a different ownership," he added. While Bahama Breeze did not meet Darden's criteria, its Italian restaurant chain, Olive Garden, has been adding locations around the world. The company has also sold some Olive Gardens to a franchise partner. "We also signed a definitive agreement to sell the eight Olive Garden locations in Canada to Recipe Unlimited, the largest full-service operator in Canada, and we are on track to close that deal soon. These eight restaurants will become franchised and upon close, Darden and Recipe Unlimited will enter into an area development agreement to open 30 more Olive Gardens over the next 10 years," Cardenas said. Those are not the only restaurant plans for Olive Garden and other Darden brands. "In addition to the agreement with Recipe Unlimited, we also have new agreements with partners in India and Spain, each of which calls for the development of 40 Olive Garden locations as well as an agreement with our existing Ruth's Chris franchise partner in Asia for the development of 6 Capital Grill locations," he added. Related: Popular BBQ chain closes almost all locations, no bankruptcy The Arena Media Brands, LLC THESTREET is a registered trademark of TheStreet, Inc.

Forbes

12 hours ago

• Forbes

Gender Gap Narrows, But Too Few Women Reach Senior Leadership, New Study Shows

New research estimates that it will take another 123 years before the world achieves full gender ... More parity. Gender parity is gaining ground in North America, and more women stepping into senior leadership roles may be a contributing factor. According to the World Economic Forum's (WEF) newly released 'Global Gender Gap Report 2025,' North America ranks highest globally in gender parity, having closed 75.8% of its overall gender gap and ranking first in the category of economic participation and opportunity. Concurrently, women now lead 11% of all Fortune 500 companies, up from 10.4% last year. There has also been progress in the number of women heading S&P 500 firms. According to the 2025 Women's Power Gap (WPG) report 'Barriers and Breakthroughs,' the total women leading S&P 500 firms went from only nine in 2000 to 48 in 2025. Notably, the report also found that women are just as, if not more, qualified as men to lead. Women Make Gains in Leadership, Yet the Climb is Still a Crawl Despite substantial gains, the number of women in CEO-level positions remains low. In fact, the world could be well over a century away from achieving true gender parity. At the current rate, WEF's report projects it will take another 123 years before the world achieves full gender parity. Plus, according to the WPG report, of the 64 new S&P 500 CEOs appointed in 2024, only 11 were women (representing just 17% of all new CEO hires), and none were founders of those companies. And among the mere 11% of Fortune 500 companies led by women, all newly appointed female CEOs were internal promotions. There's no doubt that progress has been made as more women lead some of the world's top companies. However, this progress doesn't negate the reality that men hold the vast majority of high-level leadership roles and that many women rely on internal promotions to even be considered for CEO positions. This reality is particularly concerning given that, according to the WEF's report, women make up nearly half of the global workforce, yet hold less than a third of senior leadership roles. What's more, the report from the WPG found that women are less likely than men to be promoted or mentored into CEO-track roles. When women are mainly promoted to CEO internally, but are underrepresented in senior leadership, they lack access to roles that serve as a pipeline to the top job. This further limits the pool of women positioned to become CEOs, underscoring just how far there is to go before full gender parity for women in leadership is within reach. More Women in Senior Leadership Starts With Breaking Barriers Ensuring more women have the opportunity to become CEOs begins with understanding why so few are promoted or hired into senior leadership roles. A key reason why a small number of women advance to senior leadership is the concept commonly known as the 'broken rung.' As previously reported, the broken rung refers to the systemic barriers that hinder women's advancement at every stage of their careers. In particular, the broken rung is the gap that prevents women from being promoted from entry-level to middle management positions. This critical gap in turn limits the number of women who can advance into mid-level positions, which then further limits the number who are promoted to or hired for senior leadership roles. Additionally, according to a survey conducted by and The Muse, nearly half of women say they have encountered gender-biased questions or felt discriminated against during a job interview. What's more, data from Lean In found that only 72 women are promoted and hired for every 100 men promoted and hired. This suggests that permeating gender bias in the hiring process may be what's holding back women from being hired at all levels. Fortunately, there are several effective strategies to overcome the challenges that hold women back from reaching their full potential. In its report, the WPG recommends that more companies create a pipeline to uplift women into positions with significant profit and loss experience, such as president, COO and regional or division heads. The WPG notes that profit and loss positions 'are most often the stepping stones' to CEO, yet only 24% of women make up these roles. Empowering more women to take on profit and loss experience will create more direct CEO pathways. The WPG also urges companies to audit their workplaces for bias, address selection bias in hiring practices, establish mentorship programs that support women and underrepresented groups, and ensure CEOs act as 'de facto chief talent officers' who are attuned to the experiences of those often underrepresented in senior leadership. According to the WPG, these steps are essential to supporting underrepresented groups in the workplace, guaranteeing that 'no potential leader faces obstacles for advancement.' Elevating Women into Leadership Pays Off Holding women back from senior leadership not only goes against meritocratic values, it's also simply bad for business. McKinsey's report 'Diversity wins: How inclusion matters' found that businesses ranking in the top quartile for gender diversity on executive teams were 25% more likely to have above-average profitability than companies in the lowest quartile for gender diversity at the senior level. Moreover, according to research from the National Girls Collaborative Project, companies with more women executives outperform their peers in profitability, market share, and shareholder returns. In other words, the data indicates that elevating more women to the C-suite is a business imperative. Significant strides have been made in propelling women into senior leadership, and today's corporate landscape is far more diverse than it was two decades ago. Yet, while the gender gap continues to narrow, achieving full gender parity shouldn't be 123 years away (well out of reach for even the next generation of young women). To accelerate change, it's critical that businesses take intentional steps to promote, hire, train, and mentor women at every level of an organization. Through bold action today, having full gender parity in our lifetime is within reach. And after all, the data shows it's a goal well worth investing in.